Zobrazeno 1 - 10
of 21
pro vyhledávání: '"D. S., Madhumathi"'
Autor:
Smitha Saldanha, Shina Goyal, Lokanatha Dasappa, Linu Abraham Jacob, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, D. S. Madhumathi
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 16, Iss 3 (2022)
Multiple myeloma constitutes a wide spectrum of diseases ranging from slow-growing monoclonal gammopathy of undetermined significance to rapidly progressing plasma cell leukemia. It is a very rarely diagnosed hematological malignancy in those less th
Externí odkaz:
https://doaj.org/article/0fbb05feb34b4986a2034ddd5fcb1fba
Autor:
Divya Vijayanarasimha, D S Madhumathi, Prasanna Kumari, Jayadeva Naik, L Appaji, V Lakshmidevi
Publikováno v:
Journal of Applied Hematology, Vol 8, Iss 2, Pp 61-67 (2017)
Introduction: Acute leukemia (AL) is uncommon in infants, with an annual incidence of 30 per million live births. They have peculiar biological characteristics. Although remarkable progress is seen in treatment of childhood AL, infantile AL remains a
Externí odkaz:
https://doaj.org/article/11d58304b1544e07a0b8c8e626361033
Autor:
D. S. Madhumathi, V. Lakshmidevi, Prasanna Kumari, Jayadeva Naik, Divya Vijayanarasimha, L. Appaji
Publikováno v:
Journal of Applied Hematology, Vol 8, Iss 2, Pp 61-67 (2017)
Introduction: Acute leukemia (AL) is uncommon in infants, with an annual incidence of 30 per million live births. They have peculiar biological characteristics. Although remarkable progress is seen in treatment of childhood AL, infantile AL remains a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758fb72461a5a5072837f3d7e2a94e0e
http://www.jahjournal.org/article.asp?issn=1658-5127
http://www.jahjournal.org/article.asp?issn=1658-5127
Autor:
Khandare Pravin Ashok, D S Madhumathi, Linu Abraham Jacob, S. Smitha, L K Rajeev, D Loknatha, M C Suresh Babu, K N Lokesh, A H Rudresha, Jitendra Kumar Pehalajani
Publikováno v:
Indian J Hematol Blood Transfus
The median age of diagnosis for chronic myeloid leukemia (CML) in India is 35 years on the contrary to western literature which is 47 years. The outcome of the elderly patient in CML TKI era is not reported from the Indian population. However, Wester
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::542ac574fb6bf4a4d438cb0060cafaba
https://pubmed.ncbi.nlm.nih.gov/32174690
https://pubmed.ncbi.nlm.nih.gov/32174690
Autor:
Suresh, Babu Mc, Abhishek, Anand, Kuntegowdanahalli C, Lakshmaiah, Govind, Babu K, Dasappa, Lokanatha, Linu Abraham, Jacob, D S, Madhumathi, Kadabur N, Lokesh, A H, Rudresha, L K, Rajeev, Rajesh, Patidar
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 12, Iss 2 (2018)
Background: T-cell prolymphocytic leukemia (T-PLL) is a rare lymphoid malignancy with dismal prognosis. Most patients have increased lymphocyte count (>1,00,000/dL) and widespread disease at presentation. Despite high response rate seen with alemtuzu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1bc3e7b6d2b302c51c90f2c2e2c2fe9a
https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/814
https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/814
Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia
Autor:
K C Lakshmaiah, Jacob Abraham Linu, Mc Suresh Babu, L K Rajeev, A H Rudresha, D S Madhumathi, K Govind Babu, Namratha Udupa, D. Lokanatha, K N Lokesh
Publikováno v:
ecancermedicalscience
Background Acute erythroid leukaemia (AEL) is a rare subtype of acute myeloid leukaemia (AML), constituting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9642f59888cce28332b3e891497c94a6
https://doi.org/10.3332/ecancer.2017.712
https://doi.org/10.3332/ecancer.2017.712
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Background and Objectives: This cytogenetic study detects a wide variety of common, rare and novel chromosomal abnormalities in patients with hematological disorders, providing valuable diagnostic and prognostic information. Materials and Methods: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3afeab030976ec73c573742fe92ff0
http://europepmc.org/articles/PMC3523474
http://europepmc.org/articles/PMC3523474
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 13:3825-3827
FISH is one of the most sensitive molecular methods to detect genetic abnormalities with DNA probes. When cytogenetic studies are normal or insufficient, FISH may detect cryptic rearrangements, rare or slowly proliferative abnormal populations in non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2473527d561e0557de548f999176e909
https://doi.org/10.7314/apjcp.2012.13.8.3825
https://doi.org/10.7314/apjcp.2012.13.8.3825
Autor:
D. S. Madhumathi, Jon C. Aster, Rajan R. Dighe, Satthenapalli V Ramakanth, Ankur Sharma, Krishnanand Padmanabhan, Lakshmi A. Devi, Rupali A. Gadkari, Lingappa Appaji, Annapoorni Rangarajan
Publikováno v:
Scientific Reports
Higher Notch signaling is known to be associated with hematological and solid cancers. We developed a potential immunotherapeutic monoclonal antibody (MAb) specific for the Negative Regulatory Region of Notch1 (NRR). The MAb604.107 exhibited higher a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c8747916351203a9a8af1329f8fb5d
https://pubmed.ncbi.nlm.nih.gov/26046801
https://pubmed.ncbi.nlm.nih.gov/26046801
Publikováno v:
Archives of Iranian medicine. 16(8)
The current WHO classification of hematologic malignancies defines distinct entities of myeloid disorders based on the presence of recurrent cytogenetic abnormalities. Diagnostic clonal chromosomal abnormalities provide important prognostic informati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9bde3ffaa90e554f1e0a1fe484ca3b4a
https://pubmed.ncbi.nlm.nih.gov/23906250
https://pubmed.ncbi.nlm.nih.gov/23906250